Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sphingolipids control dermal fibroblast heterogeneity.
Capolupo L, Khven I, Lederer AR, Mazzeo L, Glousker G, Ho S, Russo F, Montoya JP, Bhandari DR, Bowman AP, Ellis SR, Guiet R, Burri O, Detzner J, Muthing J, Homicsko K, Kuonen F, Gilliet M, Spengler B, Heeren RMA, Dotto GP, La Manno G, D'Angelo G. Capolupo L, et al. Among authors: mazzeo l. Science. 2022 Apr 15;376(6590):eabh1623. doi: 10.1126/science.abh1623. Epub 2022 Apr 15. Science. 2022. PMID: 35420948
Androgen receptor functions as transcriptional repressor of cancer-associated fibroblast activation.
Clocchiatti A, Ghosh S, Procopio MG, Mazzeo L, Bordignon P, Ostano P, Goruppi S, Bottoni G, Katarkar A, Levesque M, Kölblinger P, Dummer R, Neel V, Özdemir BC, Dotto GP. Clocchiatti A, et al. Among authors: mazzeo l. J Clin Invest. 2018 Dec 3;128(12):5531-5548. doi: 10.1172/JCI99159. Epub 2018 Nov 5. J Clin Invest. 2018. PMID: 30395538 Free PMC article.
Nuclear lamin A/C phosphorylation by loss of Androgen Receptor is a global determinant of cancer-associated fibroblast activation.
Ghosh S, Isma J, Mazzeo L, Toniolo A, Simon C, Dotto GP. Ghosh S, et al. Among authors: mazzeo l. bioRxiv [Preprint]. 2023 Jun 28:2023.06.28.546870. doi: 10.1101/2023.06.28.546870. bioRxiv. 2023. Update in: Nat Commun. 2024 Sep 12;15(1):7984. doi: 10.1038/s41467-024-52344-z PMID: 37425957 Free PMC article. Updated. Preprint.
An oligoclonal antibody durably overcomes resistance of lung cancer to third-generation EGFR inhibitors.
Mancini M, Gal H, Gaborit N, Mazzeo L, Romaniello D, Salame TM, Lindzen M, Mahlknecht G, Enuka Y, Burton DG, Roth L, Noronha A, Marrocco I, Adreka D, Altstadter RE, Bousquet E, Downward J, Maraver A, Krizhanovsky V, Yarden Y. Mancini M, et al. Among authors: mazzeo l. EMBO Mol Med. 2018 Feb;10(2):294-308. doi: 10.15252/emmm.201708076. EMBO Mol Med. 2018. PMID: 29212784 Free PMC article.
Histologic Transformation of ALK-Rearranged Lung Adenocarcinomas to High-Grade LCNEC: Clinical and Molecular Description of Three Cases.
Ambrosini P, Miliziano D, Liberti GD, Lorenzini D, Marchesi S, Bassetti A, Tamborini E, Leporati R, Beninato T, Mazzeo L, Brambilla M, Ganzinelli M, Prelaj A, Proto C, Braud FG, Russo GL, Occhipinti M. Ambrosini P, et al. Among authors: mazzeo l. Clin Lung Cancer. 2024 Nov 25:S1525-7304(24)00256-0. doi: 10.1016/j.cllc.2024.11.012. Online ahead of print. Clin Lung Cancer. 2024. PMID: 39665942 No abstract available.
Erratum to "Unleashing precision: A review of targeted approaches in pleural mesothelioma" [Crit. Rev. Oncol./Hematol. 203C (2024) 104481].
Occhipinti M, Brambilla M, Di Liello R, Ambrosini P, Lobianco L, Leporati R, Salvarezza M, Vitiello F, Marchesi S, Manglaviti S, Beninato T, Mazzeo L, Proto C, Prelaj A, Ferrara R, Della Corte CM, Lo Russo G, de Braud F, Ganzinelli M, Viscardi G. Occhipinti M, et al. Among authors: mazzeo l. Crit Rev Oncol Hematol. 2024 Dec;204:104521. doi: 10.1016/j.critrevonc.2024.104521. Epub 2024 Sep 23. Crit Rev Oncol Hematol. 2024. PMID: 39317528 No abstract available.
69 results